Amanote Research
Register
Sign In
Arginine Butyrate Downregulates P210 BCR-Abl Expression and Induces Apoptosis in Chronic Myelogenous Leukemia Cells
Leukemia
- United Kingdom
doi 10.1038/sj.leu.2401031
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Date
June 1, 1998
Authors
A Urbano
Y Koc
FM Foss
Publisher
Springer Science and Business Media LLC
Related search
Re-Evaluating the Role of BCR/ABL in Chronic Myelogenous Leukemia
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia
Cancer Research
Cancer Research
Oncology
MPT0B169, a New Antitubulin Agent, Inhibits BCR-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells
PLoS ONE
Multidisciplinary
Curcumin Synergistically Augments BCR/Abl Phosphorothioate Antisense Oligonucleotides to Inhibit Growth of Chronic Myelogenous Leukemia Cells
Acta Pharmacologica Sinica
Medicine
Pharmacology
P210 and P190 BCR-ABL Fusion Transcripts Variants Frequencies Among Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Sudan
International Journal of Biomedical Research
Genomic Mechanisms of P210 BCR-ABL Signaling
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Laboratory Practice Guidelines for Detecting and Reporting BCR-ABL Drug Resistance Mutations in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia
Journal of Molecular Diagnostics
Forensic Medicine
Pathology
Molecular Medicine
Cathepsin B Release After Imatinib-Mediated Lysosomal Membrane Permeabilization Triggers BCR–ABL Cleavage and Elimination of Chronic Myelogenous Leukemia Cells
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Denovo BCR-ABL Positive Acute Myelogenous Leukemia in Adult Saudi Patient-A Case Report
Journal of Cancer Prevention & Current Research
